Table of Contents Table of Contents
Previous Page  1034 / 1096 Next Page
Information
Show Menu
Previous Page 1034 / 1096 Next Page
Page Background

S1018

ESTRO 36

_______________________________________________________________________________________________

Conclusion

Alerts are an issue in the radiotherapy. This research

shows that for each patient treatment the user must deal

with 1 to 5 alerts depending on the supplier. This indicates

that bad alerts management will not lead to false

radiation. On the other hand an overkill from alerts will

lead to alerts tiredness.A linear accelerator can make over

more than one thousand alerts. For the user is unthinkable

to deal with all these alerts. But act on a random basic is

also not conceivable.

EP-1863 Risk analysis for image guided lung SBRT

A. Perez-Rozos

1

, I. Jerez-Sainz

1

, A. Roman

1

, A. Otero

1

, M.

Lobato

1

, Y. Lupiañez

1

, J. Medina

1

1

Hospital Virgen de la Victoria, Radiation Oncology.

Medical Physics., Malaga, Spain

Purpose or Objective

Stereotactic Body Radiotherapy (SBRT) is a complex

technique that reduce number of sessions and increase

fraction dose, with higher accuracy requirements. In this

work we carry out a risk analysis of our lung SBRT

simulation, planning and treatment process using Failure

Modes and Effects methodology (FMEA).

Material and Methods

FMEA analysis was performed by a multidisciplinary team

integrated by radiographers, nurses, medical physicists,

and radiation oncologists. Main steps were: identify flux

diagram of whole process, assign risk and probability for

every steps, and specific analisys of higher RPN number

steps to reduce global risk uncertainty.

Results

Main analyzed steps include: a. Simulation, b. Prescription

and treatment planning c. Preparation and treatment

verification d. Treatment delivery. Every step was then

described with higher detail. The detail degree has to be

enough to allow for clarity, but not too high to loose in

small unimportant steps.

In every substep we identifyed failures modes and effects

and risk piority numbers (RPN) were assigned, using a

score for severity, ocurrence and detection probabilities

(scores from 1 to 10). RPN numbers were promediated

between team members. Failure modes with the higher

scores were given the maximum priority to subsequent

study to apply specific QA or to take measurements to

reduce RPN number. We have identifyed 32 events, the 5

with higher scores were selected in a first stage to reduce

risk numbers. Critical steps involved isocenter transfer

and integrity between image and treatment system,

prescription errors between oncologist prescription and

electronic one, and mistakes in treatment delivery

.

Conclusion

Risk analysis in radiotheapy process must be a priority to

identify

weakness

and

reduce

uncertainty.

Multidisciplinary teams help to make flux diagrams,

identify critical steps and increase global safety.

EP-1864 Control of patients with

pacemaker/implantable cardioverter defibrillator

undergo radiotherapy.

M. Puertas Valiño

1

, A. Mendez Villamon

1

, M. Gascon

Ferrer

1

, C. Vazquez Sanchez

1

, P. Sanagustin Pedrafita

1

, J.

Castillo Lueña

1

, M. Tejedor Gutierrez

1

1

hospital universitario miguel servet, radiotherapy,

zaragoza, spain

Purpose or Objective

To establish a few basic criterias of control of the device,

in patients submitted to irradiation, without generating an

excessive load of work for the involved services and a

stress to the patient.

Material and Methods

There has been created a patient registration sheet, with

the clinical information of these and with those

parameters relating to the treatment, as well as symptoms

suffered by the patient and the information it brings over

of the functioning of the device. A protocol of action has

been established, so that when a patient of these

characteristics is considered to be subsidiary of treatment

by ionizing radiation, some procedures are carried out:

1. Consultation to the Service of Cardiology of our center,

for the first valuation.

2. Preparation of the treatment , bearing in mind, the

distance of the field of irradiation to the device. Make sure

that the device does not receive a direct, unshielded

irradiation.

3. Schedule of treatment for these patients, making easier

the control for the cardiologist of our institution.

Once the treatment sessions have finished, the final

review is realized and the opportune controls are ruled

.

Results

From the beginning of the project in March 1, 2016, there

have been radiated in our department, 16 patients with

cardiac implantable devices .

- 5 women and 11 men.

- The middle ages are 76,8 years (66 years to 86 years).

- All of them were non-pacemaker-dependent

- The tumour pathology origin of the need of irradiation

has been:

- Carcinoma of lung 8 patients.

-Carcinoma of breast 5 patients.

-Brain Metastasis 1patient.

-Cancer of rectum patient 1.

Cancer of larynx patient 1.

-The dose of radiation the patients has been variable:

between 30 Gy (300cGy/sesión) in case of cerebral

metastases, to 69.3 Gy (210 cGy/sesión) in case of the

carcinoma of larynx or an extreme hipofraccionamiento in

the SBRT of lung, with dose of 60 Gy, in meetings of

1200cGy. In two cases, the patients received concomitant

chemotherapy. - The used energies have been, in the

majority of the patients, photons of 6, 10 and 15 MV. Only

in a case of cancer of breast, the irradiation of photons

was followed by 3 meetings electrons.

The review of the device, it has not showed alterations of

this one in any case. There have been checked the

medication, syncopes, IC, as well as all the parameters of

the programming of the pacemaker or defibrillator,

without some alteration be observing.

Conclusion

In our patients some alteration has not been targeted in

the device after the irradiation, independently of the

dose. On balance, RT may be delivered safely in carefully

selected patients without the need to remove the PM/ICD

from the vicinity of the RT field.

EP-1865 The utilization of retrospective registry for

patient information of access to care

M. Siekkinen

1

, M. Stepanov

2

, A. Hammais

3

, P. Rautava

4

1

Turku University Hospital, Cancer Centre, Turku,